GSK Announces Over 1,200 Job Cuts in Belgium as Part of Restructuring Plan
GlaxoSmithKline (GSK) is planning to cut up to 1,217 jobs across its operations in Belgium. The restructuring will affect research and development, production, and international support services. According to reports from multiple Belgian media outlets, the job cuts include both white-collar workers—482 employees—and management positions—735 roles. The move is part of a broader effort by GSK to streamline its operations in Belgium as it shifts strategic priorities. The decision has raised concerns among local stakeholders about potential economic impacts and workforce displacement within key sectors supported by the pharmaceutical giant.
Tickers: $GSK
Topics: Belgium GSK job cuts restructuring
Read the full article at Seeking Alpha
Part of the story Kroger Announces Plan to Cut 3,000 Corporate Jobs Over Three Years in AI-Driven Restructuring (2 articles)